uniQure Researchers Swap Out Lead Drug for a Better Prospect Post author:Sam Post published:October 18, 2017 Post category:BioPharma The company plans to expeditiously advance AMT-061 instead of AMT-060. Source: BioSpace You Might Also Like Acadia Reports First Quarter 2017 Financial Results May 9, 2017 Flushed With Cash, Shanghai Pharma Hunts for M&A in the U.S. and Europe January 23, 2018 Nemaura Pharma Appoints As Director Of Strategic Alliances April 6, 2017
